Document:

Severance Pay Agreement and Release of All Claims (Steve Delarge)

 Exhibit 10.35 
 SEVERANCE PAY AGREEMENT AND RELEASE OF ALL CLAIMS 
 This Severance Pay Agreement and
Release of All Claims (“Agreement”) is entered into on February 27, 2012 (the “Termination Date”) between Steve Delarge (“You”) and Momentive Performance Materials Inc., (the “Company”) joined in by
Momentive Performance Materials Holdings, Inc. and Momentive Performance Materials Holdings, LLC. You have terminated your employment with the Company as of the Termination Date. You acknowledge that, throughout your employment with the Company, you
were employed at will. You further acknowledge that the Company has no obligation to provide you with any severance benefits or salary continuation other than those outlined in the term sheet signed by you on September 11, 2006. The Company
acknowledges that the termination of your employment is not a termination for Cause or a termination without Good Reason (in each case as defined in any Agreement with the Company to which you are a party or any of the Plans or Agreements referred
to in Sections 1a., b. or c. below). In consideration for your agreement to the Release contained herein and the other conditions set forth in this Agreement, the Company agrees to provide you with the following: 

 

	1.	Considerations: 

Severance Payments 
 The Company shall pay you severance compensation equal to fifteen (15) months of your current base salary. Severance payments will be made to you in equal bi-weekly installments, subject to all
applicable deductions and withholdings required by law. Deductions for cash advances and other monies due from you to the Company will be made from these payments. 
 The severance period for which these severance payments will be made will begin on February 27, 2012 and end on May 22, 2013. 

Health Care Benefit Continuation 
 Medical, prescription, vision and dental coverage under the Momentive plans will continue for you and your family at no cost until February 28, 2013. At that time, you may elect, subject to the
following paragraph, to continue health care coverage thereafter pursuant to COBRA (up to the maximum additional six months of COBRA coverage, at associate benefit rates payable by you for the period of COBRA coverage). 

If you elect to extend your healthcare coverage through COBRA, coverage will be retroactive to the first of the month following the month
of your termination. Once you elect to continue coverage pursuant to COBRA (up to maximum period of eligibility), you will be billed on a monthly basis and are obligated to pay any premiums associated with coverage after such election directly to
the third party Administrator for as long as you choose to continue coverage. 
 2011 Bonus Payment 

You will be entitled to receive any earned 2011 cash bonus to which you are entitled under the terms of the Momentive 2011 Annual
Incentive Compensation Plan. Payment will be made on a date set by the Company and concurrent with the scheduled payments to the Company’s eligible employees. You will not be eligible nor will you receive payments for any other bonuses not
specifically mentioned herein. 

 Expenses and Reimbursements 

You agree to submit any and all outstanding expenses, along with appropriate documentation, on or before February 17, 2012. All due
amounts will be paid or reimbursed by the Company in accordance with its usual expense and reimbursement policy. 
 Life
Insurance 
 Company Paid Life Insurance: 
 You will have the opportunity to convert your Life Insurance coverage to an individual policy. You must complete the conversion form with Aetna within 30 days of separation, if you chose to continue with
this benefit. 
 Company Paid Accidental Death and Dismemberment Insurance (ADD) 

Coverage will stop on your Termination Date. If you have interest in continuing coverage, please also pursue this with Aetna directly.

 Short-Term Disability 
 Coverage will cease on your last day of employment. 
 401k 

Participation and contributions end as of your last day worked. All benefits are fully vested, and you will have access to your account
through Fidelity Investments. 
 Pension and Supplementary Pension Plan 

All benefits in the Pension and Supplementary Pension Plans are fully vested and will be retained in the Plans after your Termination Date
for payment thereafter in accordance with the terms of the Pension and Supplementary Pension Plans. 
 Vacation

 You will receive payment on or before March 2, 2012 for all accrued, but unused vacation through your Termination
Date. After this date, you will not accrue or earn any additional paid vacation. 
 All Other Company Sponsored Benefit Plans

 Unless specified in this Agreement, you will cease participation in and/or accruing benefits under benefit plans sponsored
by the Company or its Affiliates (as defined below) as of your Termination Date. “Affiliate” means in the case of a Person, another Person that directly or indirectly through one or more intermediaries, controls, or is controlled by, or is
under common control with such Person. As used in this definition, the term “control,” including the correlative terms “controlling,” “controlled by” and “under common control with,” means possession, directly
or indirectly, of the power to direct or cause the direction of management or policies (whether through ownership of securities or any partnership or other ownership interest, by contract or otherwise) of a Person and the term “Person”
shall be construed broadly and shall include, without limitation, an individual, partnership, a limited liability company, a corporation, an association, a joint stock company, a trust, a joint venture, and an unincorporated organization. For
purposes of Section 15 of 

  
 2 

 
this Agreement, however, the term “Affiliate” shall not, at any time, include any portfolio companies of Apollo Management VI, L.P. or its Affiliates, other than Momentive Performance
Materials Holdings Inc. and its subsidiaries. 
 Outplacement Support 

Upon your request, the Company will arrange, at its own expense, a program for executive outplacement services to be provided to you for
up to twelve months. 
 Equity 
  

	 	a.	Stock Options Under 2007 LTIP: You, the Company and Momentive Performance Materials Holdings Inc. (“MPM Holdings”) agree that, notwithstanding anything
to the contrary contained therein, the stock options granted to you under the MPM Holdings 2007 Long-Term Incentive Plan (the “2007 LTIP”) and the Non-Qualified Stock Option Agreements (the “Option Agreements”) between you and
MPM Holdings, dated as of February 28, 2007 and December 28, 2009 (each as amended on March 5, 2010) and April 30, 2010, respectively (which now are now exercisable for units of Momentive Performance Materials Holdings LLC
(“Holdco”)) (all capitalized terms used in this paragraph, but not defined in this Agreement, shall have the meanings ascribed to them in the 2007 LTIP or Option Agreements, as the case may be), will be treated as follows: (i) all of
your Tranche A Options shall become Vested Options in accordance with the terms of the 2007 LTIP and the Option Agreements and shall remain outstanding until the expiration of the scheduled Option Term (determined without regard to the continued
service requirement or the termination provisions of Sections 7(a)(ii) through (v) of the Option Agreements) and (ii) all of your Tranche B Options and Tranche C Options shall remain outstanding until the expiration of the scheduled Option
Term (determined without regard to the continued service requirement or the termination provisions of Sections 7(a)(ii) through (v) of the Option Agreements) and shall become Vested Options if the applicable performance goals under the Option
Agreements are achieved, in accordance with the terms of the 2007 LTIP and the Option Agreements. For the avoidance of doubt, all such options shall remain subject to the provisions of Article X of the 2007 LTIP. 

 

	 	b.	 Sale of Units Converted From Common Stock: You and the Company agree that, in lieu of the right granted to you under Section 6(b) of the
Securityholders Agreement (as defined below), you shall have the right (the “Put Right”), but not the obligation, to sell to the Company or an Affiliate of the Company (as designated by the Company), and to require the Company or such
Affiliate to buy, a portion or all of the units of Holdco (“Holdco Units”) that were issued to you in connection with the Combination Agreement (as defined below), at a price of $2.594 per Holdco Unit (your original cost as adjusted
to reflect the conversion of securities under the Combination Agreement), provided you exercise such Put Right by written notice to the Company (delivered to Susan Walden at the address specified in Section 7 hereof) indicating the number of
Holdco Units you are electing to sell on or prior to May 22, 2012. The closing of any such sale of Holdco Units shall be subject to reasonable and customary documentation and shall take place within a reasonable time following receipt of such
notice. MPM Holdings and the Apollo Group (as defined in the Securityholders Agreement) each agree that it will not exercise its call rights under Section 6 of the Securityholders Agreement with respect to any Holdco Units that you hold or

  
 3 

	 	
acquire in the future. Notwithstanding the fact that the number of options originally granted to you was based on your equity ownership, MPM Holdings and the Apollo Group also agree that the sale
of such Holdco Units, if consummated at your request, will in no way impact the number of options heretofore granted to you, nor will it impact the rights and benefits of the options or remaining units you continue to own thereafter. For purposes
hereof, “Securityholders Agreement” means the Amended and Restated Securityholders Agreement, dated as of March 5, 2007, by and among the MPM Holdings and the holders that are party thereto and “Combination Agreement” means
the Combination Agreement dated September 11, 2010 between MPM Holdings and Hexion LLC (now known as Momentive Specialty Chemicals Holdings LLC). 

  

	 	c.	Equity Grants Under the 2011 Plan. You, the Company and Holdco agree that the restricted deferred units (“RDUs”) and unit options (“Unit
Options”) granted to you by Holdco under the Momentive Performance Materials Holdings LLC 2011 Equity Incentive Plan (the “2011 Plan”), the Restricted Deferred Unit Award Agreement between you and Holdco dated as of February 23,
2011 (the “RDU Agreement”) and the Unit Option Agreement between you and Holdco dated as of February 23, 2011 (the “Unit Option Agreement” and together with the RDU Agreement and 2011 Plan, the “2011 Equity
Documents”) shall continue to be governed by terms and conditions of the 2011 Equity Documents. 

  

	2.	Release of All Claims: 

In exchange for the monies and benefits given to you under this Agreement, you give up the right to bring any claims whatsoever against
the Company, its officers, employees, representatives, agents and attorneys, Affiliates and their respective successors and assigns, heirs, executors, and administrators (the “Company Released Parties”) that relate to your job, termination
from your job, or the severance and other benefits paid to you under this Agreement. You understand and agree that the Company requested that you review this Severance Pay Agreement and Release of All Claims with an attorney. The claims that you are
giving up include, but are not limited to, claims under the Age Discrimination in Employment Act, as amended (“ADEA”), Title VII of the Civil Rights Act of 1964, as amended (“Title VII”), the Civil Rights Act of 1966, as amended,
the Civil Rights Act of 1991, the Americans with Disabilities Act (“ADA”), the Equal Pay Act, as amended, the Family and Medical Leave Act, the National Labor Relations Act, as amended, the Fair Labor Standards Act, as amended, the Worker
Adjustment and Retraining Notification (“WARN”) Act, the Employee Retirement Income Security Act (“ERISA”), as amended, any and all State Workers Compensation claims of which the Company was not notified and that were not filed
prior to your Termination Date, and all other federal, state or local laws regarding rights or claims relating to employment and common law, including but not limited to, any claim for breach of an oral, implied or written employment contract;
negligent or intentional misrepresentations; wrongful discharge; defamation; negligent or intentional infliction of emotional distress; and/or violation of public policy. By signing this Agreement, you have agreed to waive your right to file any
claim with any Commission, Board or Department relating to your job or your separation from the Company. This release does not apply to any claims concerning a breach of this Agreement 

  
 4 

 
or, except to the extent specifically modified by the terms of this Agreement, any claims for vested benefits under any employee benefit plans of the Company or any affiliated Entity. 

 

	3.	Confidentiality of this Agreement: You understand and agree that this is a Confidential Agreement between you and the Company and the terms and conditions herein
are not to be revealed by you other than to your attorney, tax authorities and/or financial advisors and or your family (who may not communicate the terms and conditions of the Agreement to any third parties), all except as required by subpoena or
other process of law. 

  

	4.	Equity, Confidentiality and Proprietary Agreements: You agree that you have and will continue to be bound by the terms of the Amended and Restated
Securityholders Agreement, dated as of March 5, 2007, by and among the MPM Holdings and the holders that are party thereto (the “Securityholders Agreement”), the 2011 Equity Documents, as well as any and all confidentiality and
proprietary agreements signed by you during your employment with the Company. 

  

	5.	Acknowledgment: You received a copy of this Agreement on February 6, 2012 representing the terms of severance from the Company. No deadline of less than 21
days has been imposed upon you to sign this Agreement. If you are signing this Agreement less than 21 days from your Termination Date you understand that you do not have to do so. Changes to this Agreement do not restart the running of the 21-day
period. 

  

	6.	Cancellation Period: You may revoke this Agreement at any time within seven (7) days after signing it by providing written notice of cancellation by hand
delivery or registered mail addressed to: Susan Walden, Vice President, Human Resources at Momentive Performance Materials, Inc., 22 Corporate Woods Blvd., Albany, NY 12211. For the revocation to be effective, the Company must receive written notice
no later than the close of business on the seventh day after you sign this Agreement. If you cancel, the Company owes you nothing under this Agreement. This Agreement will not become effective and enforceable until the seven (7) day
cancellation period ends. 

  

	7.	Company Property: You agree to return your Company-provided property that may be in your possession or control on your Termination Date. You also agree to
immediately return all original and duplicate documents, files, computer files and records, policies and procedures and all other tangible things in your possession that were created, collected or received by you while employed by the Company.

  

	8.	Violation of Agreement: If you violate the material terms of this Agreement, including, but not limited to, by filing a claim against the Company or any of its
Affiliates, or by soliciting, hiring, or assisting any other person in hiring current employees of the Company or any of its Affiliated Entities (as defined below) prohibited by any proprietary agreements referred to in Section 4 hereof, and
this Agreement is upheld against you, the Company will be entitled to seek repayment of any or all of the considerations provided to you, in addition to legal fees, costs and expenses. 

  
 5 

	9.	Severability: If any part of this Agreement is found to be unenforceable, the other paragraphs will remain fully valid and enforceable to the maximum extent
permitted by law. 

  

	10.	Controlling Law/Jurisdiction: This Agreement will be interpreted, enforced and governed by and under the laws of NY, except to the extent preempted by federal
law. 

  

	11.	Future Cooperation: You agree to cooperate with the Company in investigating, prosecuting and defending any charges, claims, demands, liabilities, causes of
action, lawsuits and other proceedings by, against or involving the Company or its Affiliates, including their respective officers, agents, and employees, which relate to matters of which you have knowledge, or should have knowledge, by virtue of
your employment by the Company. The Company agrees to make reasonable efforts and accommodations to not require you to make yourself available to an extent that would unreasonably interfere with employment responsibilities you may have with another
employer. The Company will provide reimbursement for reasonable out-of-pocket expenses approved in advance. You agree to promptly notify the Company if subpoenaed or asked to appear as a witness in any matter related to the Company or one of its
Affiliates. You further agree to cooperate reasonably and sign any and all additional documents that may be necessary to carry out the terms and intent of this Agreement. 

 

	12.	Indemnification: The Company shall indemnify you against all expense, liability and loss (including but not limited to, reasonable attorney fees, judgments,
fines, amounts paid or to be paid in settlement) to the maximum extent permitted under its Certificate of Incorporation, subject to applicable law, for acts taken within the scope of your employment and your service as an officer or director of the
Company or any Affiliated Entity or as a fiduciary of any benefit plan of any of the foregoing. Further, the Company agrees that you will continue to be covered under the Company’s or Holdco’s D&O insurance, on the same basis as other
officers of the Company, for any and all claims or lawsuits that arose during the period in which you performed services for the Company or that arise at anytime during a period of six (6) years following your Termination Date.

  

	13.	Conduct: You agree to conduct yourself in a manner that does not disparage the Company or is damaging to or otherwise contrary to the Company’s best
interests. The Company agrees that its current named officers will conduct themselves in a manner that does not disparage you or is otherwise damaging to your reputation. 

 

	14.	No Known Claims / No Future Claims: To the maximum extent permitted by law, you represent and warrant that you have not filed, commenced or participated in any
way in any complaints, actions or proceedings of any kind against the Company and its Affiliates with any federal, state or local court or any administrative, regulatory or arbitration agency or body. You further agree that you will not file any
claims, and no one will file any claims on your behalf against the Company or any of its Affiliates, with respect to the claims that you have given up in this Agreement. 

 

	15.	 Non-Solicitation and Non-Competition Agreement: You agree that you are and will continue to be bound by the non-solicitation and non-competition
clauses contained in Section 9 of the Securityholders Agreement which you agreed to by executing the 

  
 6 

	 	
Adoption Agreement dated as of March 2007. In addition, in exchange for the consideration contained herein, you agree not to compete against the Company for a period of one (1) year.
Specifically you agree: 

  

	 	a.	For a period of one (1) year following your Termination Date, you shall not directly or indirectly (i) induce or attempt to induce any employee or independent
contractor of the Company or any Affiliate of the Company (collectively the “Affiliated Entities” and each such entity an “Affiliated Entity”) to leave the Company or such Affiliated Entity, or in any way interfere with the
relationship between the Company or any such Affiliated Entity and the employee or independent contractor; (ii) hire any person who is an employee or independent contractor of the Company or any Affiliated Entity until after twelve months
following such individual’s relationship with the Company or such Affiliated Entity has been terminated or (iii) induce or attempt to induce any customers (or former customers who were customers in the two (2) year period immediately
prior to such inducement or attempted inducement), supplier, licensee or other business relation of the Company or any subsidiary of the Company to cease doing business with the Company or such subsidiary or, in any way, interfere with the
relationship between any such customer, supplier, licensee or business relationship and the Company. 

  

	 	b.	For a period of one (1) year following your Termination Date, you will not directly or indirectly own, manage, operate, control, be employed by (whether as an
employee, consultant, independent contractor or otherwise, whether or not for compensation) or render any services to any person, firm, corporation or entity, in whatever form, engaged in any business of the same type as any business in which the
Company or any of its subsidiaries is engaged as of your Termination Date, or in which they have proposed prior to such date to be engaged in on or after your Termination Date, and in which you have been involved to any extent at any time during the
two (2) year period ending with your Termination Date, in any locale of the country in which the Company or any of its subsidiaries conducts business. Notwithstanding the foregoing, it shall not be a violation of this Agreement for you to join
a division or business line of a commercial enterprise with multiple divisions or business lines if such division or business line is not competitive with the businesses of the Company or any of the Affiliated Entities, provided that you perform
such services solely for such non-competitive division or business line, and perform no functions on behalf of and have no involvement with or direct or indirect responsibilities with respect to businesses competitive with the businesses of the
Company or any of the Affiliated Entities. For the avoidance of doubt, a commercial enterprise (or division or business line thereof) shall not be considered to be “competitive” with the business of the Company or any of the Affiliated
Entities if such enterprise (1) is a non-silicone and non-quartz commercial enterprise; (2) does not produce, manufacture or otherwise distribute any silicone or quartz based products and (3) does not compete with the Company or any
of the Affiliated Entities, provided that it shall be a violation of this Section if you undertake or engage in activities during the one (1) year period following your Termination Date, at such commercial enterprise intended to produce or
promote products or services that are intended to be directly competitive with the products or services of the Company or any of the Affiliated Entities. Nothing in this Section shall prohibit you from being a passive owner of not more than 4.9% of
the outstanding stock of any class of a corporation which is publicly traded, so long as you have no active participation in the business of such corporation. 

  
 7 

	16.	Entire Agreement: This Agreement is the entire agreement between you and the Company with respect to the subject matter of this Agreement. There are no other
written or oral agreements, understandings or arrangements except the ones contained in this Agreement. The terms of this Agreement may not be changed in any way except in writing, signed by you and the Company. 

 

	17.	No Mitigation: You shall not be required to mitigate the amount of any payment provided or in this Severance Pay Agreement and Release by seeking other
employment or otherwise. No payment provided for in this Severance Pay Agreement and Release shall be reduced by any compensation earned by you as the result of employment by another employer or your receipt of income from any other source.

 [Next Page is Signature Page] 

  
 8 

 FULL UNDERSTANDING: By signing this Agreement, you acknowledge that you have carefully read this
Agreement; that you have had a reasonable time to consider the language and effect of this Agreement; that the Company has informed you, in writing, to consult with an attorney before signing this Agreement; that you know, understand and agree with
the contents of this Agreement; and that you are signing this document voluntarily because you are satisfied with its terms and conditions. 
  

							
	 SIGNED:
	 		  		  	
				
	 /s/ Steve Delarge
	 		  	Dated:	  	 February 27, 2012

	Steve Delarge	 		  		  	
				
	Momentive Performance Materials Inc.	 		  		  	
				
	 /s/ Authorized Party
	 		  	Dated:	  	 February 29, 2012

				
	Momentive Performance Materials Holdings Inc.	 		  		  	
				
	 /s/ Authorized Party
	 		  	Dated:	  	 February 29, 2012

				
	Momentive Performance Materials Holdings LLC	 		  		  	
				
	 /s/ Authorized Party
	 		  	Dated:	  	 February 29, 2012

  
 9 

 CANCELLATION NOTICE 
 To cancel this Agreement: 
  

	 	•	 	 Sign below. 

  

	 	•	 	 The Company must receive this Cancellation Notice within seven (7) days of the date you signed the Agreement. 

I hereby cancel this Agreement. 
  

					
	  
	 		  	  

	 Date
	 		  	Steve Delarge

  
 10Purchase Agreement

 Exhibit 10.1 
 EXECUTION VERSION 
 $100,000,000 

H&E EQUIPMENT SERVICES, INC. 
 7% Senior Notes due 2022 
 PURCHASE AGREEMENT 

January 30, 2013 
 Deutsche
Bank Securities Inc. 
 60 Wall Street 

New York, New York 10005 
 Dear Sirs:

 1. Introductory. H&E Equipment Services, Inc., a Delaware corporation (the “Company”),
proposes, subject to the terms and conditions stated herein, to issue and sell to Deutsche Bank Securities Inc. (the “Purchaser”) U.S. $100,000,000 principal amount of its 7% Senior Notes due 2022 (the “Offered
Securities”) to be issued under that certain indenture, dated as of August 20, 2012 (the “Indenture”), by and among the Company, the Guarantors (as defined below) and The Bank of New York Mellon Trust Company, N.A., as
Trustee. 
 The Offered Securities will be unconditionally guaranteed (together, the “Guarantees”) by each of
the entities listed on Schedule A attached hereto (together, the “Guarantors”). As used herein, the term “Offered Securities” shall include the Guarantees thereof by the Guarantors, unless the context
otherwise requires. The United States Securities Act of 1933 is herein referred to as the “Securities Act.” 

The Company has previously issued $530,000,000 in aggregate principal amount of its 7% Senior Notes due 2022 under the Indenture (the
“Existing Notes”). The Offered Securities constitute an issuance of “Additional Notes” under the Indenture. Except as otherwise described in the General Disclosure Package (as defined below), the Offered Securities will
have identical terms to the Existing Notes and will be treated as a single class of notes for all purposes under the Indenture. 

The Offered Securities will be offered and sold to the Purchaser without registration under the Securities Act in reliance upon an
exemption therefrom. Upon the original issuance thereof, and until such time as the same is no longer required under the applicable requirements of the Securities Act, the Offered Securities shall bear the legends set forth in the Final Offering
Memorandum (as defined below). The Purchaser has advised the Company that the Purchaser will make offers to sell (the “Exempt Resales”) the Offered Securities purchased by the Purchaser on the terms set forth in the General
Disclosure Package solely (i) in the United States to persons whom the Purchaser reasonably believes to be “qualified institutional buyers” (“QIBS”) as defined in Rule 144A under the Securities Act, and
(ii) outside the United States to non-U.S. persons in reliance upon Regulation S under the Securities Act (the purchasers specified in clauses (i) and (ii) being referred to herein as the “Eligible Purchasers.”

 The holders of the Offered Securities will be entitled to the benefits of a Registration Rights Agreement to be dated as of
the Closing Date by and among the Company, the Guarantors and the Purchaser (the “Registration Rights Agreement”), pursuant to which the Company and the Guarantors agree to file a registration statement with the Securities Exchange
Commission (the “Commission”) to exchange the Offered Securities for a new issue of substantially identical debt securities issued under the indenture and registered under the Securities Act, subject to the terms and conditions
specified therein. 

 The Company and the Guarantors hereby agree with the Purchaser as follows: 

2. Representations and Warranties of the Company and the Guarantors. The Company and the Guarantors, jointly and severally,
represent and warrant to, and agree with, the Purchaser that: 
 (a) A preliminary offering memorandum dated as
of January 30, 2013, as amended and supplemented from time to time prior to the date hereof (the “Preliminary Offering Memorandum”) relating to the Offered Securities to be offered by the Purchaser and a final offering
memorandum (the “Final Offering Memorandum”) disclosing the offering price and other final terms of the Offered Securities and is dated as of the date of this Agreement (even if finalized and issued subsequent to the date of this
Agreement) have been or will be prepared by the Company. “General Disclosure Package” means the Preliminary Offering Memorandum, together with any Issuer Free Writing Communication (as hereinafter defined) existing at the Applicable
Time (as hereinafter defined) which is intended for general distribution to prospective investors, as evidenced by its being specified in Schedule B to this Agreement (including the pricing supplement listing the final terms of the Offered
Securities and their offering, included in Schedule B to this Agreement, which is referred to as the “Pricing Supplement”). “Applicable Time” means 10:00 a.m. (New York time) on the date of this Agreement. As
of the date of this Agreement, the Final Offering Memorandum does not include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. At the Applicable Time neither (i) the General Disclosure Package, nor (ii) any individual Supplemental Marketing Material (as hereinafter defined), when considered together with the General Disclosure
Package, included any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The preceding two
sentences do not apply to statements in or omissions from the Preliminary Offering Memorandum or Final Offering Memorandum, the General Disclosure Package or any Supplemental Marketing Material based upon written information furnished to the Company
by or on behalf of any Purchaser specifically for use therein, it being understood and agreed that the only such information is that described as such in Section 8(b) hereof. 

“Free Writing Communication” means a written communication (as such term is defined in Rule 405 under the Securities Act)
that constitutes an offer to sell or a solicitation of an offer to buy the Offered Securities and is made by means other than the Preliminary Offering Memorandum or the Final Offering Memorandum. “Issuer Free Writing Communication”
means a Free Writing Communication prepared by or on behalf of the Company, used or referred to by the Company or containing a description of the final terms of the Offered Securities or of their offering. “Supplemental Marketing
Material” means any Issuer Free Writing Communication specified on Schedule D to this Agreement. 

(b) The Company has been duly incorporated and is an existing corporation in good standing under the laws of the State of
Delaware, with corporate power and authority to own its properties and conduct its business as described in the General Disclosure Package; and the Company is duly qualified to do business as a foreign corporation in good standing in all other
jurisdictions in which its ownership or lease of property or the conduct of its business requires such qualification, except where any such failure to be so qualified or be in good standing in such other jurisdictions would not, individually or in
the aggregate, have a material adverse effect on the condition (financial or otherwise), business, properties or results of operations of the Company and its subsidiaries taken as a whole (a “Material Adverse Effect”). 

  
 -2-

 (c) Each subsidiary of the Company has been duly incorporated or organized
and is an existing corporation or limited liability company in good standing under the laws of the jurisdiction of its incorporation or organization, with corporate or limited liability company power and authority to own its properties and conduct
its business as described in the General Disclosure Package; and each subsidiary of the Company is duly qualified to do business as a foreign corporation or limited liability company in good standing in all other jurisdictions in which its ownership
or lease of property or the conduct of its business requires such qualification; except where the failure to be so qualified or be in good standing in such other jurisdictions would not, individually or in the aggregate, have a Material Adverse
Effect; all of the issued and outstanding capital stock or other equity interests of each subsidiary of the Company has been duly authorized and validly issued and is fully paid and nonassessable; and the capital stock or other equity interests of
each subsidiary owned by the Company, directly or through subsidiaries, is owned free from liens, encumbrances and defects, except for any lien or encumbrance in connection with the Third Amended and Restated Credit Agreement, dated as of
July 29, 2010, by and among the Company, each of its subsidiaries, General Electric Capital Corporation, as Agent, Bank of America, N.A. as co-syndication agent, documentation agent, joint lead arranger and joint bookrunner and the lenders
party thereto (the “Credit Agreement”), as amended as of the date hereof (the “Credit Agreement Liens”). 
 (d) The Indenture has been and the Offered Securities have been or, as of the Closing Date, will have been, duly authorized by the Company and the Guarantors, as applicable. The Indenture has been duly
executed and delivered by the Company and the Guarantors and, assuming due authorization, execution and delivery by the Trustee, constitutes a valid and legally binding obligation of the Company and the Guarantors, enforceable against the Company
and the Guarantors in accordance with its terms, subject to (i) bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and other similar laws now or hereafter in effect of, relating to or affecting creditors’ rights
generally, and (ii) general principles of equity (whether considered in a proceeding at law or in equity) and the discretion of the court or other body before which any proceeding therefor may be brought. When the Offered Securities have been
duly executed, authenticated and delivered by the Trustee in accordance with the terms of the Indenture, and the Offered Securities have been issued and delivered by the Company to the Purchaser against payment therefor on the Closing Date in
accordance with the terms of this Agreement, the Offered Securities will be validly issued and delivered, will conform in all material respects to the description thereof contained in the Final Offering Memorandum and in the General Disclosure
Package, will be in the form contemplated by the Indenture, and will constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their terms, subject to (i) bankruptcy, insolvency,
reorganization, moratorium, fraudulent transfer and other similar laws now or hereafter in effect of, relating to or affecting creditors’ rights generally, and (ii) general principles of equity (whether considered in a proceeding at law or
in equity) and the discretion of the court or other body before which any proceeding therefor may be brought. 

(e) There are no contracts, agreements or understandings between the Company and any person that would give rise to a
valid claim against the Company or the Purchaser for a brokerage commission, finder’s fee or other like payment in connection with the offering and sale of the Offered Securities. 

  
 -3-

 (f) Assuming the accuracy of the Purchaser’s representations and
warranties and the Purchaser’s compliance with the agreements in Section 4 hereof and compliance with the limitations and restrictions contained under the heading “Transfer Restrictions” in the Final Offering Memorandum, no
consent, approval, authorization, or order of, or filing with, any governmental agency or body or any court is required to be obtained or made by the Company for the consummation of the transactions contemplated by this Agreement or the Registration
Rights Agreement in connection with the issuance and sale of the Offered Securities by the Company and the delivery of the Guarantees by the Guarantors except (i) registration of the Registered Exchange Offer (as defined in the Registration
Rights Agreement) or resale of the Offered Securities under the Securities Act pursuant to the Registration Rights Agreement, and the order of the Commission declaring effective the Exchange Offer Registration Statement and, if required, the Shelf
Registration Statement (each as defined in the Registration Rights Agreement); (ii) qualification of the Indenture under the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”) in connection with the issuance of
the Exchange Securities (as defined in the Registration Rights Agreement); (iii) such as may be required under state securities or blue sky laws; (iv) such as have been obtained or made prior to the Closing Date; and (v) such as would
not individually or in the aggregate, materially and adversely affect the ability of the Company to perform its obligations under this Agreement. 
 (g) The execution, delivery and performance by the Company and the Guarantors of this Agreement and the Registration Rights Agreement, and the issuance and sale of the Offered Securities will not result
in a breach or violation of any of the terms and provisions of, or constitute a default under, (i) any statute, any rule, regulation or order of any governmental agency or body or any court, domestic or foreign, having jurisdiction over the
Company or any subsidiary of the Company or any of their properties, (ii) any agreement or instrument to which the Company or any such subsidiary is a party or by which the Company or any such subsidiary is bound or to which any of the
properties of the Company or any such subsidiary is subject or (iii) the charter or by-laws of the Company or any such subsidiary, (except, in the case of clauses (i) and (ii), where any such breach, violation or default would not,
individually or in the aggregate, have a Material Adverse Effect). The Company has full corporate power and authority to authorize, issue and sell the Offered Securities and each Guarantor has full corporate or limited liability company power and
authority, as applicable, to deliver their respective Guarantees, in each case as contemplated by this Agreement. 
 (h) This Agreement has been duly authorized, executed and delivered by the Company and each Guarantor. 
 (i) Except for the Credit Agreement Liens and such other liens existing as of the date hereof which are not prohibited under the Credit Agreement, the Company and its subsidiaries have good and marketable
title to all real properties and good and valid title to all other properties and assets owned by them, in each case free from liens, encumbrances and defects that would, individually or in the aggregate, have a Material Adverse Effect; and except
as disclosed in the General Disclosure Package, the Company and its subsidiaries hold any leased real or personal property under valid and enforceable leases with no exceptions that would, individually or in the aggregate, have a Material Adverse
Effect. 
 (j) The Company and its subsidiaries possess adequate certificates, authorities or permits issued by
appropriate governmental agencies or bodies necessary to conduct the business now operated by them except such certificates, authorities or permits which the failure to possess would not individually or in the aggregate, have a Material Adverse
Effect, and have not received any notice of proceedings relating to the revocation or modification of any such certificate, authority or permit that if determined adversely to the Company or any of its subsidiaries, would, individually or in the
aggregate, have a Material Adverse Effect. 

  
 -4-

 (k) No labor dispute with the employees of the Company or any subsidiary
exists or, to the knowledge of the Company or any Guarantor, is imminent that would reasonably be expected to have a Material Adverse Effect. 
 (l) The Company and its subsidiaries own, possess or can acquire on reasonable terms, adequate trademarks, trade names and other rights to inventions, know-how, patents, copyrights, confidential
information and other intellectual property (collectively, “intellectual property rights”) necessary to conduct the business now operated by them, or presently employed by them, except where the failure to own, possess or acquire
such intellectual property rights would not, individually or in the aggregate, have a Material Adverse Effect, and have not received any notice of infringement of or conflict with asserted rights of others with respect to any intellectual property
rights that, if determined adversely to the Company or any of its subsidiaries, would individually or in the aggregate have a Material Adverse Effect. 
 (m) Neither the Company nor any of its subsidiaries is in violation of any statute, any rule, regulation, decision or order of any governmental agency or body or any court having jurisdiction over the
Company or any of its subsidiaries or any of their respective properties, domestic or foreign, relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the environment or human
exposure to hazardous or toxic substances (collectively, “environmental laws”), owns or operates any real property contaminated with any substance that is subject to any environmental laws, is liable for any off-site disposal or
contamination pursuant to any environmental laws, or is subject to any claim relating to any environmental laws, which violation, contamination, liability or claim would individually or in the aggregate have a Material Adverse Effect; and the
Company is not aware of any pending investigation which might lead to such a claim. 
 (n) There are no pending
actions, suits or proceedings against or affecting the Company, any of its subsidiaries or any of their respective properties that, if determined adversely to the Company or any of its subsidiaries, would individually or in the aggregate have a
Material Adverse Effect, or would materially and adversely affect the ability of the Company and the Guarantors taken as a whole to perform their obligations under the Indenture, this Agreement or the Registration Rights Agreement, or which are
otherwise material in the context of the sale of the Offered Securities; and, to the Company’s knowledge, no such actions, suits or proceedings are threatened. 

(o) The financial statements included in the General Disclosure Package present fairly in all material respects the
consolidated financial position of the Company and its consolidated subsidiaries as of the dates shown and their results of operations and cash flows for the periods shown, and, except as otherwise disclosed in the General Disclosure Package, such
financial statements have been prepared in conformity with the generally accepted accounting principles in the United States (“GAAP”) applied on a consistent basis; and the assumptions used in preparing the pro forma financial
statements included in the General Disclosure Package provide a reasonable basis for presenting the significant effects directly attributable to the transactions or events described therein, the related pro forma adjustments give appropriate effect
to those assumptions, and the pro forma columns therein reflect the proper application of those adjustments to the corresponding historical financial statement amounts. 

  
 -5-

 (p) Since the date of the latest audited financial statements included in
the General Disclosure Package there has been no material adverse change, nor any development or event involving a prospective material adverse change, in the condition (financial or other), business, properties or results of operations of the
Company and its subsidiaries taken as a whole, and, except as disclosed in or contemplated by the General Disclosure Package, there has been no dividend or distribution of any kind declared, paid or made by the Company or any Guarantor on any class
of their capital stock. 
 (q) The Company is subject to the reporting requirements of either Section 13 or
Section 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) and files reports with the Commission on the Next Generation EDGAR System. 

(r) None of the Company or the Subsidiaries is or will be on the Closing Date an “investment company” or
“promoter” or “principal underwriter” for an “investment company,” as such terms are defined in the Investment Company Act of 1940, as amended, and the rules and regulations thereunder. 

(s) No securities of the same class (within the meaning of Rule 144A(d)(3) under the Securities Act) as the Offered
Securities are listed on any national securities exchange registered under Section 6 of the Exchange Act or quoted in a U.S. automated inter-dealer quotation system. 

(t) The offer and sale of the Offered Securities by the Company and the Guarantors to the Purchaser in the manner
contemplated by this Agreement will be exempt (assuming that the representations and warranties and agreements in Section 4 of this Agreement are true and correct and the Purchaser complies with the offer and sale procedures set forth in this
Agreement) from the registration requirements of the Securities Act by reason of Section 4(2) thereof and Regulation S thereunder. 
 (u) Except for the issuance of the Existing Notes, neither the Company, nor any Guarantor, nor any of their Affiliates (as defined in Rule 501(b) of Regulation D under the Act), nor any person acting on
their behalf (it being understood that no representation, warranty, covenant or agreement is made with respect to the Purchaser or any of its affiliates or representatives) (i) has, within the six-month period prior to the date hereof, offered
or sold in the United States or to any U.S. person (as such terms are defined in Regulation S under the Securities Act) the Offered Securities, or any security of the same class or series as the Offered Securities or (ii) has offered or will
offer or sell the Offered Securities (A) in the United States by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) under the Securities Act or (B) with respect to any such securities sold in
reliance on Rule 903 of Regulation S (“Regulation S”) under the Securities Act, by means of any directed selling efforts within the meaning of Rule 902(c) of Regulation S. The Company, the Guarantors and their Affiliates and any
person acting on their behalf (it being understood that no representation, warranty, covenant or agreement is made with respect to the Purchaser or any of its affiliates or representatives) have complied and will comply with the offering
restrictions requirement of Regulation S. Neither the Company nor any Guarantor has entered or will enter into any contractual arrangement with respect to the distribution of the Offered Securities except for this Agreement and the Registration
Rights Agreement. 
 (v) The entities listed on Schedule C hereto are the only subsidiaries, direct or
indirect, of the Company. 

  
 -6-

 (w) Assuming (i) the accuracy of the Purchaser’s representations
and warranties and the Purchaser’s compliance with the agreements in Section 4 hereof and compliance with the limitations and restrictions contained under the heading “Transfer Restrictions” in the Final Offering Memorandum, and
(ii) that the purchasers in the Exempt Resales are Eligible Purchasers, no qualification of the Indenture under the Trust Indenture Act is required in connection with the offer and sale of the Offered Securities as contemplated hereby.

 (x) On the Closing Date, the Exchange Securities will have been duly authorized by the Company; and when duly
executed, authenticated and issued in accordance with the terms of the Indenture and the Registered Exchange Offer, the Exchange Securities will be entitled to the benefits of the Indenture and will constitute valid and legally binding obligations
of the Company, enforceable against the Company in accordance with their terms, subject to (i) bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and other similar laws now or hereafter in effect of, relating to or
affecting creditors’ rights generally, and (ii) general principles of equity (whether considered in a proceeding at law or in equity) and the discretion of the court or other body before which any proceeding therefor may be brought.

 (y) On the Closing Date, the Guarantee to be endorsed on the Exchange Securities by each Guarantor will have
been duly authorized by such Guarantor; and, when such Guarantee has been duly executed and issued in accordance with the terms of the Indenture and the Exchange Offer and when the Exchange Securities have been duly executed, authenticated and
issued in accordance with the terms of the Indenture and the Exchange Offer, the Guarantee of each Guarantor endorsed on such Exchange Securities will constitute valid and legally binding obligations of such Guarantor, enforceable against such
Guarantor in accordance with its terms, subject to (i) bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and other similar laws now or hereafter in effect of, relating to or affecting creditors’ rights generally, and
(ii) general principles of equity (whether considered in a proceeding at law or in equity) and the discretion of the court or other body before which any proceeding therefor may be brought. 

(z) The Registration Rights Agreement has been duly authorized by the Company and each of the Guarantors and, on the
Closing Date, will have been duly executed and delivered by the Company and each of the Guarantors. When the Registration Rights Agreement has been duly executed and delivered, the Registration Rights Agreement will be a valid and binding agreement
of the Company and each of the Guarantors, enforceable against the Company and each Guarantor in accordance with its terms, subject to (i) bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and other similar laws now or
hereafter in effect of, relating to or affecting creditors’ rights generally, (ii) general principles of equity (whether considered in a proceeding at law or in equity) and the discretion of the court or other body before which any
proceeding therefor may be brought and (iii) the limitations of state and federal securities laws with respect to indemnity and contribution provisions. On the Closing Date, the Registration Rights Agreement will conform in all material
respects as to legal matters to the description thereof in the General Disclosure Package and the Final Offering Memorandum. 
 (aa) Except as disclosed in the General Disclosure Package and except as contemplated by (i) the Registration Rights Agreement and (ii) the Registration Rights Agreement, dated August 20,
2012, by and among the Company, the Guarantors and the initial purchasers named therein relating to the Existing Notes (the “Existing Registration Rights Agreement”), there are no contracts, agreements or understandings between the
Company or any Guarantor and any person granting such person the right to require the Company or such Guarantor to file a registration statement under the Securities Act with respect to any securities of the Company or such Guarantor or to require
the Company or such Guarantor to include such securities with the Offered Securities and Guarantees registered pursuant to the Registration Rights Agreement. 

  
 -7-

 (bb) Neither the Company nor any of its subsidiaries nor any agent (it being
understood that no representation, warranty, covenant or agreement is made with respect to any Purchaser or any of its affiliates or representatives) thereof acting on the behalf of them has taken, and none of them will take, any action that might
cause this Agreement or the issuance or sale of the Offered Securities to violate Regulation T, Regulation U or Regulation X of the Board of Governors of the Federal Reserve System. 

(cc) No “nationally recognized statistical rating organization” as such term is defined for purposes of Rule
436(g)(2) under the Securities Act (i) has imposed (or has informed the Company that it is considering imposing) any condition (financial or otherwise) on the Company’s retaining any rating assigned to the Company or any securities of the
Company or (ii) has informed the Company that it is considering (a) the downgrading, suspension, or withdrawal of, any rating so assigned or (b) any negative or adverse change in the outlook for any rating of the Company or any
securities of the Company or any Guarantor. 
 (dd) Assuming (i) the accuracy of the Purchaser’s
representations and warranties and the Purchaser’s compliance with the agreements in Section 4 hereof and compliance with the limitations and restrictions contained under the heading “Transfer Restrictions” in the Final Offering
Memorandum, and (ii) that the purchasers in the Exempt Resales are Eligible Purchasers, no registration under the Securities Act is required for the sale of the Offered Securities to the Purchaser as contemplated hereby or for Exempt Resales.

 (ee) Each of the Company and the Subsidiaries (i) makes and keeps accurate books and records and
(ii) maintains internal accounting controls that provide reasonable assurance that (A) transactions are executed in accordance with management’s authorization, (B) transactions are recorded as necessary to permit preparation of
its financial statements and to maintain accountability for its assets, (C) access to its assets is permitted only in accordance with management’s authorization and (D) the reported accountability for its assets is compared with
existing assets at reasonable intervals. The Company and the Subsidiaries maintain systems of “internal control over financial reporting” (as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the
Exchange Act and have been designed by, or under the supervision of, management to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles. 
 (ff) Each of the Company and the Subsidiaries has filed all
necessary federal, state and foreign income and franchise tax returns (or has requested and received extensions thereof) and has pad all taxes shown due thereon, except where the failure to so file such returns or pay such taxes would not,
individually or in the aggregate, have a Material Adverse Effect; and other than tax deficiencies that the Company or any Subsidiary is contesting in good faith and for which the Company or such Subsidiary has provided adequate reserves, there is no
tax deficiency that has been asserted against the Company or any of the Subsidiaries that would have, individually or in the aggregate, a Material Adverse Effect. 

(gg) The statistical and market-related data included in the General Disclosure Package are based on or derived from
sources that the Company and the Subsidiaries believe to be reliable and accurate. 

  
 -8-

 (hh) Each of the Company and the Subsidiaries carries insurance in such
amounts and covering such risks as is adequate for the conduct of its business and the value of its properties. 

(ii) None of the Company or the Subsidiaries has any material liability for any prohibited transaction or funding
deficiency or any complete or partial withdrawal liability with respect to any pension, profit sharing or other plan that is subject to the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), to which the Company
or any of the Subsidiaries makes or ever has made a contribution and in which any employee of the Company or of any Subsidiary is or has ever been a participant. With respect to such plans, the Company and each Subsidiary is in compliance in all
material respects with all applicable provisions of ERISA. 
 (jj) Immediately after the consummation of the
transactions contemplated by this Agreement, the fair value and present fair saleable value of the assets of each of the Company and the Subsidiaries (each on a consolidated basis) will exceed the sum of its stated liabilities and identified
contingent liabilities; none of the Company or the Subsidiaries (each on a consolidated basis) is, nor will any of the Company or the Subsidiaries (each on a consolidated basis) be, immediately after giving effect to the execution, delivery and
performance of this Agreement, and the consummation of the transactions contemplated hereby, (a) left with unreasonably small capital with which to carry on its business as it is proposed to be conducted, (b) unable to pay its debts
(contingent or otherwise) as they mature or (c) otherwise insolvent. 
 (kk) None of the Company or the
Subsidiaries has taken, nor will any of them take, directly or indirectly, any action designed to, or that might be reasonably expected to, cause or result in stabilization or manipulation of the price of the Offered Securities. 

(ll) Neither the Company nor any of the Subsidiaries nor, to the best knowledge of the Company and each of the Guarantors,
any director, officer, agent, employee, Affiliate or other person acting on behalf of the Company or any of the Subsidiaries has: (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating
to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of the Foreign Corrupt Practices
Act of 1977 (the “FCPA”); or (iv) made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment. 
 (mm) The operations of the Company and the Subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and
Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any
governmental agency (collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of the Subsidiaries
with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened. 

(nn) Neither the Company nor any of the Subsidiaries nor, to the knowledge of the Company, any director, officer, agent,
employee or Affiliate of the Company or any of the Subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will not
directly or indirectly use the proceeds of the offering contemplated hereby, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the
activities of any person currently subject to any U.S. sanctions administered by OFAC. 

  
 -9-

 3. Purchase, Sale and Delivery of Offered Securities. On the basis of the
representations, warranties and agreements and subject to the terms and conditions set forth herein, the Company agrees to sell to the Purchaser, and the Purchaser agrees to purchase from the Company, at a purchase price of 107.25% of the principal
amount thereof plus accrued interest from August 20, 2012 to the Closing Date (as hereinafter defined), the Offered Securities. 
 The Company will deliver against payment of the purchase price the Offered Securities to be offered and sold by the Purchaser in reliance on Regulation S (the “Regulation S Securities”)
in the form of one or more permanent global Securities in registered form without interest coupons (the “Regulation S Global Securities”) which will be deposited with the Trustee as custodian for The Depository Trust Company
(“DTC”) for the respective accounts of the DTC participants for Morgan Guaranty Trust Company of New York, Brussels office, as operator of the Euroclear System (“Euroclear”), and Clearstream Banking,
société anonyme (“Clearstream, Luxembourg”) and registered in the name of Cede & Co., as nominee for DTC. The Company will deliver against payment of the purchase price the Offered Securities to be purchased
by the Purchaser hereunder and to be offered and sold by the Purchaser in reliance on Rule 144A under the Securities Act (the “144A Securities”) in the form of one or more permanent global securities in definitive form without
interest coupons (the “Restricted Global Securities”) deposited with the Trustee as custodian for DTC and registered in the name of Cede & Co., as nominee for DTC. The Regulation S Global Securities and the Restricted
Global Securities shall be assigned separate CUSIP numbers. The Regulation S Global Securities and the Restricted Global Securities shall include the legend regarding restrictions on transfer set forth under “Transfer Restrictions” in the
Final Offering Memorandum. Until the termination of the distribution compliance period (as defined in Regulation S) with respect to the offering of the Offered Securities, interests in the Regulation S Global Securities may only be held by the DTC
participants for Euroclear and Clearstream, Luxembourg. Interests in any permanent global securities will be held only in book-entry form through Euroclear, Clearstream, Luxembourg or DTC, as the case may be, except in the limited circumstances
described in the Final Offering Memorandum. 
 Payment for the Regulation S Securities and the 144A Securities shall be made by
the Purchaser in Federal (same day) funds by wire transfer to an account at a bank designated by the Company and reasonably acceptable to the Purchaser at 10:00 A.M., (New York time), on February 4, 2013, or at such other time not later than
seven full business days thereafter as the Purchaser and the Company determine, such time being herein referred to as the “Closing Date,” against delivery to the Trustee as custodian for DTC of (i) the Regulation S Global Securities
representing all of the Regulation S Securities and (ii) the Restricted Global Securities representing all of the 144A Securities. The Regulation S Global Securities and the Restricted Global Securities will be made available for checking at
the office of Cahill Gordon and Reindel LLP at least 24 hours prior to the Closing Date. 
 4. Representations
by Purchaser; Resale by Purchaser. 
 (a) The Purchaser represents and warrants to the Company that it is a QIB within the
meaning of Rule 144A under the Securities Act (“Rule 144A”) under the Act and an institutional “accredited investor” within the meaning of Regulation D under the Securities Act. 

(b) The Purchaser acknowledges that the Offered Securities have not been registered under the Securities Act and may not be offered or
sold within the United States or to, or for the account or benefit of, U.S. persons except in accordance with Regulation S or pursuant to an exemption from the registration requirements of the Securities Act. 

  
 -10-

 (c) The Purchaser represents and agrees that it will offer the Offered Securities for resale
only upon the terms and conditions set forth in this Agreement, the Preliminary Offering Memorandum, the General Disclosure Package and the Final Offering Memorandum and it will solicit offers to buy the Offered Securities only from, and will offer
and sell the Offered Securities solely (i) to persons reasonably believed by the Purchaser to be QIBs in accordance with Rule 144A or, if any such person is buying for one or more institutional accounts for which such person is acting as
fiduciary or agent, only when such person has represented to the Purchaser that each such account is a QIB, to whom notice has been given that such sale or delivery is being made in reliance on Rule 144A, and, in each case, in transactions
under Rule 144A, and (ii) outside the United States to non-U.S. persons in reliance upon Regulation S under the Securities Act; provided, however, that, in the case of this clause (ii), in purchasing such Offered Securities
such persons shall have represented and agreed as provided under the caption “Transfer Restrictions” contained in the General Disclosure Package and the Final Offering Memorandum. 

(d) The Purchaser represents and warrants with respect to offers and sales outside the United States that (i) the Offered Securities
have not been and will not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except in accordance with Regulation S under the Act or pursuant to an exemption from the registration requirements of the
Act; and (ii) it has offered the Offered Securities and will offer and sell the Offered Securities (A) as part of its distribution at any time and (B) otherwise until 40 days after the later of the commencement of the offering and the
Closing Date, only in accordance with Rule 903 of Regulation S and, accordingly, neither such purchaser nor its affiliates nor any persons acting on its or their behalf have engaged or will engage in any directed selling efforts (within the meaning
of Regulation S) with respect to the Offered Securities, and any such persons have complied and will comply with the offering restrictions requirement of Regulation S. 
 (e) The Purchaser agrees that it and each of its affiliates has not entered and will not enter into any contractual arrangement with respect to the distribution of the Offered Securities except with the
prior written consent of the Company. 
 (f) The Purchaser agrees that it and each of its affiliates will not offer or sell the
Offered Securities in the United States by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) under the Securities Act, including, but not limited to (i) any advertisement, article, notice or
other communication published in any newspaper, magazine or similar media or broadcast over television or radio, or (ii) any seminar or meeting whose attendees have been invited by any general solicitation or general advertising. The Purchaser
agrees, with respect to resales made in reliance on Rule 144A of any of the Offered Securities, to deliver either with the confirmation of such resale or otherwise prior to settlement of such resale a notice to the effect that the resale of such
Offered Securities has been made in reliance upon the exemption from the registration requirements of the Securities Act provided by Rule 144A. 
 (g) The Purchaser represents and agrees that (i) it has only communicated or caused to be communicated and will only communicate or cause to be communicated any invitation or inducement to engage in
investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000 (the “FSMA”)) received by it in connection with the issue or sale of any Offered Securities in circumstances in which section 21(1)
of the FSMA does not apply to the Issuer or any of the Guarantors; and (ii) it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the Offered Securities in, from or
otherwise involving the United Kingdom. 

  
 -11-

 (h) In relation to each Member State of the European Economic Area which has implemented the
Prospectus Directive (each, a “Relevant Member State”), the Purchaser represents and agrees that with effect from and including the date on which the Prospectus Directive is implemented in that Relevant Member State it has not made
and will not make an offer of the Offered Securities to the public in that Relevant Member State other than (i) to any legal entity which a qualified investor as defined in the Prospectus Directive, (ii) to fewer than 100, or, if the
Relevant Member State has implemented the relevant provision of the 2010 PD Amending Directive, 150, natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive,
subject to obtaining the prior consent of the Purchaser for any such offer, or (iii) in any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of Offered Securities shall require the
Company to publish a prospectus pursuant to Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the Prospectus Directive. For the purposes of this provision, the expression an “offer of Offered Securities
to the public” in relation to any Offered Securities in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the Offered Securities to be offered so as to enable
an investor to decide to purchase or subscribe to the Offered Securities, as the same may be varied in that Relevant Member State by any measure implementing the Prospectus Directive in that Relevant Member State, the expression “Prospectus
Directive” means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State), and includes any relevant implementing measure in each Relevant Member
State and the expression “2010 PD Amending Directive” means Directive 2010/73/EU. 
 5. Certain Agreements
of the Company and the Guarantors. The Company agrees, and, as applicable, the Guarantors agree, with the Purchaser that: 
 (a) The Company will advise the Purchaser promptly of any proposal to amend or supplement the Preliminary Offering Memorandum, Final Offering Memorandum or General Disclosure Package and will not effect
such amendment or supplementation without the Purchaser’s consent, which shall not be unreasonably withheld. If, at any time prior to the completion of the Exempt Resales of the Offered Securities by the Purchaser, there occurs an event or
development as a result of which any document included in the Preliminary Offering Memorandum, Final Offering Memorandum, or the General Disclosure Package as then amended or supplemented, included or would include an untrue statement of a material
fact or omitted or would omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, the Company promptly will notify the Purchaser of such event
and promptly will prepare, at its own expense, an amendment or supplement which will correct such statement or omission. Neither the Purchaser’s consent to, nor the Purchaser’s delivery to offerees or investors of, any such amendment or
supplement shall constitute a waiver of any of the conditions set forth in Section 7. The first sentence of this subsection does not apply to statements in or omissions from the Preliminary Offering Memorandum, Final Offering Memorandum or the
General Disclosure Package made in reliance upon and in conformity with written information furnished to the Company by or on behalf of the Purchaser specifically for use therein, it being understood and agreed that the only such information is that
described as such in Section 8(b) hereof. 
 (b) The Company will furnish to the Purchaser copies of the
Preliminary Offering Memorandum, each other document comprising a part of the General Disclosure Package, the Final Offering Memorandum, and all amendments and supplements thereto, in each case as soon as practicable and in such quantities as the
Purchaser reasonably requests. At any time when the Company is not subject to Section 13 or 15(d) of the Exchange Act, for so long as any Offered 

  
 -12-

 
Securities remain outstanding that are “restricted securities” within the meaning of Rule 144(a)(3) of the Securities Act, the Company will promptly furnish or cause to be furnished to
the Purchaser and, upon request of holders and prospective purchasers of the Offered Securities, to such holders and purchasers, copies of the information required to be delivered to holders and prospective purchasers of the Offered Securities
pursuant to Rule 144A(d)(4) under the Securities Act (or any successor provision thereto) in order to permit compliance with Rule 144A in connection with resales by such holders of the Offered Securities. The Company will pay the expenses of
printing and distributing to the Purchaser all such documents. 
 (c) The Company will apply the net proceeds
from the sale of the Offered Securities as set forth under “Use of Proceeds” in the General Disclosure Package and the Final Offering Memorandum. 
 (d) For so long as any of the Offered Securities remain outstanding, the Company will furnish to the Purchaser copies of all reports and other communications (financial or otherwise) furnished by the
Company to the Trustee or to the holders of the Offered Securities and, as soon as available, copies of any reports or financial statements furnished to or filed by the Company with the Commission or any national securities exchange on which any
class of securities of the Company may be listed (it being understood and agreed that any reports or financial statements filed with the Commission and available through the Commission’s Next Generation EDGAR System shall be deemed to have been
furnished to the Purchaser pursuant to this clause (d)). 
 (e) None of the Company or any of its Affiliates will
sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any “security” (as defined in the Act) that could be integrated with the sale of the Offered Securities in a manner which would require the registration
under the Act of the Offered Securities. 
 (f) The Company will use its commercially reasonable efforts to
permit the Offered Securities to be eligible for clearance and settlement through The Depository Trust Company. 

(g) The Company will cooperate with the Purchaser and counsel for the Purchaser to qualify or register the Offered
Securities for sale under (or obtain exemptions from the application of) the applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Purchaser designates and will continue such qualifications, registrations,
and exemptions in effect so long as required for the Exempt Resales of the Offered Securities by the Purchaser; provided, however, that none of the Company nor the Guarantors shall be obligated to qualify or register as a foreign corporation or as a
dealer in securities or to take any action that would subject it to general service of process in any such jurisdiction where it is not presently qualified or registered or where it would be subject to taxation, and provided, further, that none of
the Company or the Guarantors will be required to file a registration statement or prospectus except as contemplated by the Registration Rights Agreement or the Existing Registration Rights Agreement. 

(h) During the period of two years after the Closing Date, the Company will, upon request, furnish to the Purchaser and
any holder of Offered Securities a copy of the restrictions on transfer applicable to the Offered Securities. 

(i) None of the Company or the Subsidiaries is, or immediately after the sale of the Offered Securities to be sold
hereunder and the application of the proceeds from such sale (as described in the General Disclosure Package and the Final Offering Memorandum under the caption “Use of Proceeds”) will be, an “investment company” as such term is
defined in the Investment Company Act of 1940, as amended. 

  
 -13-

 (j) During the period of one year after the Closing Date (or such shorter
period as may be provided for in Rule 144 under the Securities Act, as the same may be in effect from time to time), the Company will not, and will not permit any of its affiliates (as defined in Rule 144 under the Securities Act) to, resell any of
the Offered Securities that constitute “restricted securities” that have been reacquired by any of them, except pursuant to an effective registration statement under the Securities Act. 

(k) The Company will pay all expenses incidental to the performance of its obligations under this Agreement, the Indenture
and the Registration Rights Agreement, including (i) the fees and expenses of the Trustee and its professional advisers; (ii) all expenses in connection with the execution, issue, authentication, packaging and initial delivery of the
Offered Securities and, as applicable, the Exchange Securities (as defined in the Registration Rights Agreement), the preparation and printing of this Agreement, the Registration Rights Agreement, the Offered Securities, the Preliminary Offering
Memorandum, any other documents comprising any part of the General Disclosure Package, the Final Offering Memorandum, all amendments and supplements thereto, each item of Supplemental Marketing Material and any other document relating to the
issuance, offer, sale and delivery of the Offered Securities and as applicable, the Exchange Securities; (iii) the cost of any advertising approved by the Company in connection with the issue of the Offered Securities; (iv) for any
expenses (including reasonable fees and disbursements of counsel) incurred in connection with qualification of the Offered Securities or the Exchange Securities for sale under the state securities laws of such jurisdictions in the United States and
Canada as the Purchaser designates and the printing of memoranda relating thereto; (v) for any fees charged by investment rating agencies for the rating of the Offered Securities or the Exchange Securities; and (vi) for expenses incurred
in distributing the Preliminary Offering Memorandum, any other documents comprising any part of the General Disclosure Package, the Final Offering Memorandum (including any amendments and supplements thereto) and any Supplemental Marketing Material
to the Purchaser. Except as otherwise expressly provided in this Agreement, the Purchaser shall pay their own costs and expenses, including the costs and expenses of their counsel and any transfer taxes on the Offered Securities they may sell.

 (l) In connection with the offering, until the Purchaser shall have notified the Company of the completion of
the resale of the Offered Securities, neither the Company nor any Guarantor, will permit its affiliates (as defined in Rule 144 of the Securities Act) to, either alone or with one or more other persons, bid for or purchase for any account in which
the Company or any Guarantor or any of their affiliates has a beneficial interest in any Offered Securities or attempt to induce any person to purchase any Offered Securities; and neither the Company nor any Guarantor will, and the Company will not
permit its affiliates (as defined in Rule 144 of the Securities Act) to, make bids or purchases for the purpose of creating actual, or apparent, active trading in, or of raising the price of, the Offered Securities. 

(m) For a period of 90 days after the date of the initial offering of the Offered Securities by the Purchaser, neither the
Company nor any Guarantor will offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, or file with the Commission a registration statement under the Securities Act (other than (i) the Exchange Offer Registration
Statement or the Shelf Registration Statement or (ii) any registration statement contemplated by the Existing Registration Rights Agreement, in each case) relating to, any United States dollar-denominated debt securities issued or guaranteed by
the Company and having a maturity of more than one year 

  
 -14-

 
from the date of issue (other than (i) the Exchange Securities, (ii) the securities to which any registration statement contemplated by the Existing Registration Rights Agreement
relates, or (iii) any amendment to or increase in the Company’s or any of its subsidiaries’ bank lending facilities, including its senior secured credit facility), without the prior written consent of the Purchaser. Neither the
Company nor any Guarantor will at any time offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, any securities under circumstances where such offer, sale, pledge, contract or disposition would cause the exemption
afforded by Section 4(2) of the Securities Act or the safe harbor of Regulation S thereunder to cease to be applicable to the offer and sale of the Offered Securities. 
 6. Free Writing Communications. 
 (a) The Company represents and agrees
that, unless it obtains the prior consent of the Purchaser, it has not made and will not make any offer relating to the Offered Securities that would constitute an Issuer Free Writing Communication. The Purchaser represents and agrees that, unless
it obtains the prior consent of the Company it has not made and will not make any offer relating to the Offered Securities that would constitute a Free Writing Communication. 
 (b) The Company consents to the use by any Purchaser of a Free Writing Communication that contains only (A) information consistent with the Preliminary Offering Memorandum describing the preliminary
terms of the Offered Securities or their offering or (B) information that describes the final terms of the Offered Securities or their offering and that is included in Schedule B hereto it being understood and agreed that any such Free Writing
Communication referred to in Section 6(b) hereof shall not be an Issuer Free Writing Communication for purposes of this Agreement. 
 7. Conditions of the Obligations of the Purchaser. The obligations of the Purchaser to purchase and pay for the Offered Securities will be subject to the accuracy of the representations and
warranties on the part of the Company and the Guarantors herein, to the accuracy of the statements of officers of the Company made pursuant to the provisions hereof to the performance by the Company and the Guarantors of their respective obligations
hereunder and to the following additional conditions precedent: 
 (a) On the date hereof, the Purchaser shall
have received from BDO USA, LLP a comfort letter dated the date hereof, in form and substance reasonably satisfactory to counsel for the Purchaser with respect to the audited and any unaudited or pro forma financial information in the General
Disclosure Package. On the Closing Date, the Purchaser shall have received from BDO USA, LLP a comfort letter dated the Closing Date, in form and substance reasonably satisfactory to counsel for the Purchaser, which shall refer to the comfort letter
dated the date hereof and reaffirm or update as of a more recent date, the information stated in the comfort letter dated the date hereof and similarly address the audited and any unaudited or pro forma financial information in the Final
Offering Memorandum. 
 (b) Subsequent to the execution and delivery of this Agreement, there shall not have
occurred (i) any of the Company or its subsidiaries having sustained any loss or interference with respect to its businesses or properties from fire, flood, hurricane, accident or other calamity, whether or not covered by insurance, or from any
strike, labor dispute, slow down or work stoppage or any legal or governmental proceeding, which loss or interference, in the judgment of the Purchaser, has had or has a Material Adverse Effect, or there shall have been, in the judgment of the
Purchaser, any event or development that, individually or in the aggregate, has or could be reasonably likely to have a Material Adverse Effect (including without limitation a change in control of the Company or its subsidiaries), except in each
case as described in the General Disclosure 

  
 -15-

 
Package and the Final Offering Memorandum (exclusive of any amendment or supplement thereto); (ii) any downgrading in the rating of any debt securities of the Company or any of the
Guarantors by any “nationally recognized statistical rating organization” (as defined for purposes of Rule 436(g) under the Securities Act), or any public announcement that any such organization has under surveillance or review its rating
of any debt securities of the Company or any of the Guarantors (other than an announcement with positive implications of a possible upgrading, and no implication of a possible downgrading, of such rating) or any announcement that the Company or any
of the Guarantors has been placed on negative outlook; (iii) any material change in the financial markets of the United States if, in the judgment of the Purchaser, the effect of any such material change makes it impractical or inadvisable to
proceed with completion of the offering or sale of and payment for the Offered Securities, (iv) any material suspension or material limitation of trading in securities generally on the New York Stock Exchange or NASDAQ National Market, or any
setting of minimum prices for trading on such exchange; (v) or any suspension of trading of any securities of the Company on any exchange or in the over-the-counter market; (vi) any banking moratorium declared by U.S. Federal or New York
authorities; (vii) any major disruption of settlements of securities or clearance services in the United States or (viii) any (A) outbreak or escalation of hostilities involving the United States or (B) outbreak or escalation of
any other insurrection or armed conflict involving the United States or any other national or international calamity or emergency, if, in the judgment of the Purchaser, the effect of any such outbreak, escalation, calamity or emergency makes it
impractical or inadvisable to proceed with completion of the offering or sale of and payment for the Offered Securities. 
 (c) The Purchaser shall have received (A) an opinion and 10b-5 letter, dated as of the Closing Date and addressed to the Purchaser, of Dechert LLP, counsel for the Company in form and substance
reasonably satisfactory to counsel to the Purchaser; and (B)(i) the opinions, dated as of the Closing Date and addressed to the Purchaser, of Garlington, Lohn & Robinson, PLLP, local Montana counsel for the Company and Guarantors and
Williams Mullen, local Virginia counsel for the Company and the Guarantors (collectively, “Local Counsel”), in each case, in form and substance reasonably satisfactory to counsel for the Purchaser. In rendering such opinions,
Dechert LLP and Local Counsel shall have received and may rely upon any certificates and other documents and information as they may reasonably request to pass upon such matters. 

(d) The Purchaser shall have received the opinion and 10b-5 letter, in form and substance satisfactory to the Purchaser,
dated as of the Closing Date and addressed to the Purchaser, of Cahill Gordon & Reindel LLP, counsel for the Purchaser, with respect to certain legal matters relating to this Agreement and such other related matters as the
Purchaser may reasonably require. In rendering such opinion, Cahill Gordon & Reindel LLP shall have received and may rely upon such certificates and other documents and information as it may reasonably request to pass upon
such matters. 
 (e) The Purchaser shall have received a certificate, dated the Closing Date, of the Chief
Executive Officer, the President or any Vice President and a principal financial or accounting officer of the Company and each Guarantor in which such officers, to their knowledge, shall state that the representations and warranties of the Company
and the Guarantors in this Agreement are true and correct, that the Company and the Guarantors have satisfied all conditions on their part to be performed or satisfied hereunder and complied in all material respects with all agreements at or prior
to the Closing Date, and that, subsequent to the date of the most recent financial statements in the General Disclosure Package there has been no material adverse change, nor any development or event involving a prospective material adverse change,
in the condition (financial or other), business, properties or results of operations of the Company and its subsidiaries taken as a whole except as set forth in the General Disclosure Package or as described in such certificate. 

  
 -16-

 (f) The sale of the Offered Securities hereunder shall not be enjoined
(temporarily or permanently) on the Closing Date. 
 (g) On the Closing Date, the Purchaser shall have received
the Registration Rights Agreement executed by the Company and such agreement shall be in full force and effect. 
 The Company
will furnish the Purchaser with such conformed copies of such opinions, certificates, letters and documents as the Purchaser reasonably request. The Purchaser may waive compliance with any conditions to the obligations of the Purchaser hereunder.

 8. Indemnification and Contribution. 
 (a) The Company and the Guarantors will indemnify and hold harmless the Purchaser, its officers, partners, members, directors and its affiliates and each person, if any, who controls the Purchaser within
the meaning of Section 15 of the Securities Act, against any losses, claims, damages or liabilities, joint or several, to which the Purchaser may become subject, under the Securities Act or the Exchange Act or otherwise, insofar as such losses,
claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the Preliminary Offering Memorandum, General Disclosure Package or the
Final Offering Memorandum, in each case as amended or supplemented, or any Supplemental Marketing Material or any Issuer Free Writing Communication, or arise out of or are based upon the omission or alleged omission to state therein a material fact
necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading and will reimburse the Purchaser for any legal or other expenses reasonably incurred by the Purchaser in connection with
investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred; provided, however, that the Company and the Guarantors will not be liable in any such case to the extent that any such loss, claim, damage or
liability arises out of or is based upon an untrue statement or alleged untrue statement in or omission or alleged omission from any of such documents in reliance upon and in conformity with written information furnished to the Company by or on
behalf of the Purchaser through itself or its counsel specifically for use therein, it being understood and agreed that the only such information consists of the information described as such in subsection (b) below. 

(b) The Purchaser will indemnify and hold harmless the Company and each Guarantor, their directors and officers and each person, if any,
who controls the Company and each Guarantor within the meaning of Section 15 of the Securities Act, against any losses, claims, damages or liabilities to which the Company and each Guarantor may become subject, under the Securities Act or the
Exchange Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the Preliminary
Offering Memorandum or the Final Offering Memorandum, in each case as amended or supplemented, or any Supplemental Marketing Material or any Issuer Free Writing Communication or arise out of or are based upon the omission or the alleged omission to
state therein a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged
untrue statement or omission or alleged omission was made in reliance upon and in conformity with written information furnished to the Company by or on behalf of the Purchaser through itself or its counsel specifically for use therein, and will
reimburse any legal or other expenses reasonably incurred by the Company and the Guarantors in connection with investigating or defending any such loss, claim, damage, liability 

  
 -17-

 
or action as such expenses are incurred, it being understood and agreed that the only such information furnished by the Purchaser consists of the following information in the Preliminary and
Final Offering Memorandum furnished on behalf of the Purchaser: the information set forth in the last paragraph on the front cover page (as such paragraph is supplemented by Schedule B); under the caption “Private Placement” the
second, third and fourth sentences of the third paragraph, the second sentence of the ninth paragraph and the tenth paragraph. 

(c) Promptly after receipt by an indemnified party under this Section of notice of the commencement of any action, such indemnified party
will, if a claim in respect thereof is to be made against the indemnifying party under subsection (a) or (b) above, notify the indemnifying party of the commencement thereof; but the failure to notify the indemnifying party shall not
relieve it from any liability that it may have under subsection (a) or (b) above except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and provided further
that the failure to notify the indemnifying party shall not relieve it from any liability that it may have to an indemnified party otherwise than under subsection (a) or (b) above. In case any such action is brought against any indemnified
party and it notifies the indemnifying party of the commencement thereof, the indemnifying party will be entitled to participate therein and, to the extent that it may wish, jointly with any other indemnifying party similarly notified, to assume the
defense thereof with counsel reasonably satisfactory to such indemnified party (who shall not, except with the consent of the indemnified party, be counsel to the indemnifying party), and after notice from the indemnifying party to such indemnified
party of its election so to assume the defense thereof the indemnifying party will not be liable to such indemnified party under this Section for any legal or other expenses subsequently incurred by such indemnified party in connection with the
defense thereof other than reasonable costs of investigation. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened action in respect of which any indemnified
party is or could have been a party and indemnity could have been sought hereunder by such indemnified party unless such settlement includes (i) an unconditional release of such indemnified party from all liability on any claims that are the
subject matter of such action and (ii) does not include a statement as to or an admission of fault, culpability or failure to act by or on behalf of any indemnified party. 
 (d) If the indemnification provided for in this Section is unavailable or insufficient to hold harmless an indemnified party under subsection (a) or (b) above, then each indemnifying party shall
contribute to the amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities referred to in subsection (a) or (b) above (i) in such proportion as is appropriate to reflect the relative
benefits received by the Company and the Guarantors on the one hand and the Purchaser on the other from the offering of the Offered Securities or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in
such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company and the Guarantors on the one hand and the Purchaser on the other in connection with the
statements or omissions which resulted in such losses, claims, damages or liabilities as well as any other relevant equitable considerations. The relative benefits received by the Company and the Guarantors on the one hand and the Purchaser on the
other shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the Company bear to the total discounts and commissions received by the Purchaser. The relative fault shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company, the Guarantors or the
Purchaser and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The amount paid by an indemnified party as a result of the losses, claims, damages or
liabilities referred to in the first sentence of this subsection (d) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any action or

  
 -18-

 
claim which is the subject of this subsection (d). Notwithstanding the provisions of this subsection (d), the Purchaser shall not be required to contribute any amount in excess of the amount by
which the total price at which the Offered Securities purchased by it were resold exceeds the amount of any damages which the Purchaser has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged
omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. 

(e) The obligations of the Company and the Guarantors under this Section shall be in addition to any liability which the Company may
otherwise have and shall extend, upon the same terms and conditions, to each person, if any, who controls any Purchaser within the meaning of the Securities Act or the Exchange Act; and the obligations of the Purchaser under this Section shall be in
addition to any liability which the Purchaser may otherwise have and shall extend, upon the same terms and conditions, to each person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act. 

9. Survival of Certain Representations and Obligations. The respective indemnities, agreements, representations, warranties
and other statements of the Company and the Guarantors or their officers and of the Purchaser set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation, or statement as to the results
thereof, made by or on behalf of any Purchaser, the Company, the Guarantors or any of their respective representatives, officers or directors or any controlling person, and will survive delivery of and payment for the Offered Securities. If for any
reason the purchase of the Offered Securities by the Purchaser is not consummated, the Company and the Guarantors shall remain jointly and severally responsible for the expenses to be paid or reimbursed by them pursuant to Section 5 and the
respective obligations of the Company, the Guarantors and the Purchaser pursuant to Section 8 shall remain in effect. If the purchase of the Offered Securities by the Purchaser is not consummated for any reason other than solely because of the
occurrence of any event specified in clause (iii), (iv), (vi), (vii) or (viii) of Section 7(b), the Company and the Guarantors will reimburse, jointly and severally, the Purchaser for all out-of-pocket expenses (including reasonable
fees and disbursements of counsel) reasonably incurred by it in connection with the offering of the Offered Securities. 
 10.
Notices. All communications hereunder will be in writing and, if sent to the Purchaser will be mailed, delivered or telegraphed and confirmed to the Purchaser, c/o Deutsche Bank Securities, Inc. 60 Wall Street, New York, NY 10005,
Attention: High Yield Syndicate Desk, Third Floor, with a copy to the attention of the General Counsel, 36th Floor, with a copy to Cahill Gordon & Reindel LLP, 80 Pine Street, New York, NY 10005, Attention: John Tripodoro,
Esq., or, if sent to the Company or any Guarantor, will be mailed, delivered or telegraphed and confirmed to the Company and such Guarantor at H&E Equipment Services, Inc., 7500 Pecue Lane, Baton Rouge, LA 70809, Attention: Chief Financial
Officer, with a copy to Dechert LLP, 1095 Avenue of the Americas, New York, NY 10036, Attention: Richard Goldberg, Esq.; provided, however, that any notice to the Purchaser pursuant to Section 8 will be mailed, delivered or telegraphed and
confirmed to the Purchaser. 
 11. Successors. This Agreement will inure to the benefit of and be binding upon the
parties hereto and their respective successors and the officers and directors and controlling persons referred to in Section 8, and no other person will have any right or obligation hereunder. 

12. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an
original, but all such counterparts shall together constitute one and the same Agreement. 

  
 -19-

 13. Absence of Fiduciary Relationship. The Company acknowledges and agrees
that: 
 (a) the Purchaser has been retained solely to act as initial purchaser in connection with the initial
purchase, offering and resale of the Offered Securities and that no fiduciary, advisory or agency relationship between the Company or the Guarantors and the Purchaser has been created in respect of any of the transactions contemplated by this
Agreement or the Preliminary Offering Memorandum, General Disclosure Package or Final Offering Memorandum, irrespective of whether the Purchaser has advised or is advising the Company or any Guarantor on other matters; 

(b) the purchase price of the Offered Securities set forth in this Agreement was established by the Company following
discussions and arms-length negotiations with the Purchaser and the Company is capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated by this Agreement; 

(c) the Company and the Guarantors have been advised that the Purchaser and its affiliates are engaged in a broad range of
transactions which may involve interests that differ from those of the Company and the Guarantors and that the Purchaser has no obligation (except as required under federal securities laws) to disclose such interests and transactions to the Company
or any Guarantor by virtue of any fiduciary, advisory or agency relationship; and 
 (d) the Company and the
Guarantors waive, to the fullest extent permitted by law, any claims they may have against the Purchaser for breach of fiduciary duty or alleged breach of fiduciary duty in connection with the transactions contemplated by this Agreement or the
process leading thereto and agrees that the Purchaser shall have no liability (whether direct or indirect) to the Company or any Guarantor in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on behalf of or in
right of the Company or any Guarantor, including stockholders, employees or creditors of the Company or any Guarantor. 
 14.
Applicable Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York without regard to principles of conflicts of laws. 

The Company and the Guarantors hereby submit to the non-exclusive jurisdiction of the Federal and state courts in the Borough of
Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. 

  
 -20-

 If the foregoing is in accordance with the Purchaser’s understanding of our agreement
kindly sign and return to the Company one of the counterparts hereof, whereupon it will become a binding agreement among the Company, the Guarantors and the Purchaser in accordance with its terms. 

 

			
	Very truly yours,
	
	H&E EQUIPMENT SERVICES, INC.
		
	By:	 	/s/ LESLIE S. MAGEE
		 	Name: Leslie S. Magee
		 	Title: Chief Financial Officer
	
	GNE INVESTMENTS, INC.
		
	By:	 	/s/ LESLIE S. MAGEE
		 	Name: Leslie S. Magee
		 	Title: Chief Financial Officer
	
	GREAT NORTHERN EQUIPMENT, INC.
		
	By:	 	/s/ LESLIE S. MAGEE
		 	Name: Leslie S. Magee
		 	Title: Chief Financial Officer
	
	H&E CALIFORNIA HOLDING, INC.
		
	By:	 	/s/ LESLIE S. MAGEE
		 	Name: Leslie S. Magee
		 	Title: Chief Financial Officer
	
	H&E EQUIPMENT SERVICES (CALIFORNIA), LLC
		
	By:	 	/s/ LESLIE S. MAGEE
		 	Name: Leslie S. Magee
		 	Title: Chief Financial Officer
	
	H&E FINANCE CORP.
		
	By: 	 	/s/ LESLIE S. MAGEE
		 	Name: Leslie S. Magee
		 	Title: Chief Financial Officer

 [PURCHASE AGREEMENT] 

 
			
	H&E EQUIPMENT SERVICES (MID-ATLANTIC), INC.
		
	By: 	 	/s/ LESLIE S. MAGEE
		 	Name: Leslie S. Magee
		 	Title: Chief Financial Officer

 [PURCHASE AGREEMENT] 

					
	The foregoing Purchase Agreement
	    is hereby confirmed and accepted
	    as of the date first above written.
	
	BY DEUTSCHE BANK SECURITIES INC.
			
		 	By: 	 	/S/ CHASE ARNOLD
		 		 	Name: Chase Arnold
		 		 	Title: Director
			
		 	By:	 	/S/ CHRISTOPHER BLUM
		 		 	Name: Christopher Blum
		 		 	Title: Managing Director

 [PURCHASE AGREEMENT] 

 SCHEDULE A 
 Guarantors 
 GNE Investments, Inc., a Washington corporation

 Great Northern Equipment Inc., a Montana corporation 
 H&E California Holding, Inc., a California corporation 
 H&E Equipment
Services (California), LLC, a Delaware limited liability company 
 H&E Equipment Services (Mid-Atlantic), Inc., a Virginia
corporation 
 H&E Finance Corp., a Delaware corporation 

 SCHEDULE B 
 Pricing Supplement attached hereto as Annex B-1. 

 Annex B-1 
 Pricing Supplement dated January 30, 2013 to 
 Preliminary Offering
Memorandum 
 Dated January 30, 2013 (the “Preliminary Offering Memorandum”) 

$100,000,000 
  

 
 H&E Equipment Services, Inc. 

7% Senior Notes due 2022 

This Pricing Supplement is qualified in its entirety by reference to the Preliminary Offering Memorandum, which is hereby incorporated by reference. The
information in this Pricing Supplement supplements the Preliminary Offering Memorandum and supersedes the information in the Preliminary Offering Memorandum to the extent inconsistent with the information in the Preliminary Offering Memorandum. The
New Notes have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) or any securities laws of any state. The New Notes are being offered only to (1) “qualified institutional buyers” as
defined in Rule 144A under the Securities Act and (2) outside the United States to non-U.S. persons in compliance with Regulation S under the Securities Act. 
 On August 20, 2012, H&E Equipment Services, Inc. (“H&E”) issued $530,000,000 aggregate principal amount of 7% Senior Notes due 2022 (the “Existing Notes”) pursuant to an
indenture dated as of August 20, 2012 among the Company, the guarantors party thereto and The Bank of New York Mellon Trust Company, N.A., as Trustee (as amended and supplemented, the “Indenture”). The notes offered hereby (the
“New Notes”) are being issued as additional notes under the Indenture. The Existing Notes and the New Notes are collectively referred to in this Supplement as the “Notes.” 
 Unless otherwise indicated, terms used but not defined herein have the meaning assigned to such terms in the Preliminary Offering Memorandum. 

 

			
	 Issuer:
	  	H&E Equipment Services, Inc.
	 Aggregate Principal Amount:
	  	$100,000,000. The New Notes will have the same terms and will be part of the same class as the Existing Notes.
	 Title of Securities:
	  	7% Senior Notes due 2022
	 Final Maturity Date:
	  	September 1, 2022
	 Issue Price:
	  	108.5%, plus accrued interest from August 20, 2012
		
	 Coupon:
	  	7%
	 Interest Payment Dates:
	  	March 1 and September 1

			
	 First Interest Payment Date:
	  	March 1, 2013
		
	 Record Dates:
	  	February 15 and August 15 of each year
		
	 Optional Redemption:
	  	 At any time prior to September 1, 2017, H&E may redeem all or a part of the Notes upon notice as described under the heading
“Description of Notes — Repurchase at the Option of Holders — Selection and Notice,” at a redemption price equal to 100% of the principal amount of the Notes redeemed plus the Applicable Premium as of, and accrued
and unpaid interest and Additional Interest, if any, to, but excluding the date of redemption, subject to the rights of holders of record on the relevant record date to receive interest due on the relevant interest payment date.

 
 On or after September 1, 2017, H&E may redeem all or a part of the Notes upon
not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as percentages of principal amount) set forth below plus accrued and unpaid interest and Additional Interest, if any, on the Notes redeemed, to the applicable
redemption date, if redeemed during the twelve-month period beginning on September 1 of the years indicated below, subject to the rights of holders of Notes on the relevant record date to receive interest on the relevant interest payment
date:

  

					
	 Date
	  	Price	 
	 2017
	  	 	103.500	% 
	 2018
	  	 	102.333	% 
	 2019
	  	 	101.167	% 
	 2020 and thereafter
	  	 	100.000	% 

  

			
		  	 “Applicable Premium” means, with respect to any Note on any redemption date, the greater of:

 
 (1)    1.0% of the
principal amount of such Note; and
  

(2)    the excess, if any, of (a) the present value at such redemption date of (i) the
redemption price of such note at September 1, 2017 (such redemption price being set forth in the table appearing above under the caption “—Optional redemption”), plus (ii) all required interest payments due on such Note through
September 1, 2017 (excluding accrued but unpaid interest to the redemption date), computed using a discount rate equal to the Treasury Rate as of such redemption date plus 50 basis points, over (b) the then outstanding principal amount of such
Note.
  
 “Treasury Rate” means, as of any redemption date,
the yield to maturity as of such redemption date of United States Treasury securities with a constant maturity (as compiled and published in the most recent Federal Reserve Statistical Release H.15 (519) that has become publicly available at least
two Business Days

			
		  	prior to the redemption date (or, if such Statistical Release is no longer published, any publicly available source of similar market data)) most nearly equal to the period from
the redemption date to September 1, 2017; provided, however, that if the period from the redemption date to September 1, 2017 is less than one year, the weekly average yield on actively traded United States Treasury securities
adjusted to a constant maturity of one year will be used.
	 Optional Redemption with Equity Proceeds:
	  	At any time prior to September 1, 2015, H&E may on any one or more occasions redeem up to 35% of the aggregate principal amount of Notes issued under the indenture at a
redemption price of 107.000% of the principal amount, plus accrued and unpaid interest and Additional Interest, if any, on the Notes to be redeemed to the redemption date, with the net cash proceeds of one or more Equity Offerings of H&E;
provided that: (1) at least 65% of the aggregate principal amount of Notes originally issued under the indenture (excluding Notes held by H&E and its Subsidiaries) remains outstanding immediately after the occurrence of such redemption;
and (2) the redemption occurs within 90 days of the date of the closing of such Equity Offering.
		
	 Change of Control:
	  	101%
	 Initial Purchaser:
	  	Deutsche Bank Securities Inc.
		
	 Trade Date:
	  	January 30, 2013
		
	 Settlement Date:
	  	February 4, 2013 (T+3)
	 Distribution:
	  	144A and Regulation S with registration rights as set forth in the Preliminary Offering Memorandum
		
	 CUSIP/ISIN Numbers:
	  	 144A CUSIP: 404030 AD0
  

144A ISIN: US404030AD03
  
 Regulation S CUSIP: U2443LAC5
  

Regulation S ISIN: USU2443LAC55

 The information (including financial information) presented in the Preliminary Offering Memorandum is deemed to have
changed to the extent affected by the changes described herein. 
 This material is confidential and is for your information only and is
not intended to be used by anyone other than you. This information does not purport to be a complete description of these securities or the offering. Please refer to the offering memorandum for a complete description. 

This communication is being distributed in the United States solely to qualified institutional buyers, as defined in Rule 144A under the Securities
Act and outside the United States solely to non-U.S. persons as defined under Regulation S in accordance with the applicable provisions of Regulation S. 
 This communication is not an offer to sell the securities and it is not a solicitation of an offer to buy the securities in any jurisdiction where the offering is prohibited, where the person making
the offer is not qualified to do so, or to any person who cannot legally be offered the securities. 

 This communication is directed only to persons who (i) are persons falling within Article 19(5)
(“Investment professional”) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Financial Promotion Order”), (ii) are persons falling within Article 49(2)(a) to
(d) (“High net worth companies, unincorporated associations, etc.”) of the Financial Promotion Order, (iii) are outside the United Kingdom, (iv) are persons falling within Article 43(2) of the Financial Promotion Order
(“Members and creditors of certain bodies corporate”), or (v) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in
connection with the issue or sale of any Notes may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”). This communication is directed only at relevant persons
and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this communication relates is available only to relevant persons and will be engaged in only with relevant persons.

 Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such
disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. 

 SCHEDULE C 
 Subsidiaries 
 GNE Investments, Inc., a Washington corporation

 Great Northern Equipment, Inc., a Montana corporation 
 H&E California Holding, Inc., a California corporation 
 H&E Equipment
Services (California), LLC, a Delaware limited liability company 
 H&E Equipment Services (Mid-Atlantic), Inc., a Virginia
corporation 
 H&E Finance Corp., a Delaware corporation 

 SCHEDULE D 
 Supplemental Marketing Material 
 l. NetRoadshow road show presentation posted on
January 30, 2013 and accompanying audio recording posted on January 30, 2013.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00212-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00212-of-00352.parquet"}]]